Ad
related to: nejm journal
Search results
NEJM rescinds ban on embargoed physician-focused publications
Becker’s Hospital Review· 6 days agoThe New England Journal of Medicine rescinded its policy that banned physician-focused ...
Promising results for hyperlipidemia treatment reduce risk of cardiovascular events
Medical Xpress· 2 hours agoThe results, published in the latest edition of the New England Journal ...
Novo Nordisk defends $1,000 Ozempic list price
Becker’s Hospital Review· 10 hours agoNovo Nordisk is contesting Sen. Bernie Sanders' calls to reduce the list prices of Ozempic and Wegovy in the U.S., Bloomberg reports.
Arrowhead's much-anticipated cholesterol drug hits the mark again in phase 2 hyperlipidemia trial
FierceBiotech· 4 hours agoThe company presented results from the midstage MUIR study of plozasiran at the 92nd European...
Exact Sciences (EXAS) to Showcase Favorable Research Outcome
Zacks via Yahoo Finance· 3 hours agoExact Sciences' (EXAS) latest study research result shows commitment to innovation and strategies...
Feeding children peanuts reduces allergy risk by 71pc
The Telegraph via Yahoo News· 58 minutes ago“Peanut allergy can be especially challenging to live with. We know from the many people we support...
Wegovy injections for weight loss: Side effects and benefits
Daily Telegraph· 4 days agoAlthough available on the NHS since September 2023 after being approved by the National Institute...
Bird flu in Florida? Safe to consume chicken and milk? How the outbreak can affect you
Miami Herald via Yahoo News· 8 hours agoThe study was recently published in the New England Journal of Medicine ...
England to pick Maro Itoje despite just 169 minutes left on playing limit
The Telegraph via Yahoo Sports· 6 hours agoEngland will take Maro Itoje on tour to Japan and New Zealand despite the Saracens second row being...
Novo’s Ozempic slashes risk of death in kidney disease study
Detroit News· 4 days agoPatients with kidney disease caused by diabetes were one-fifth less likely to die of any cause...
